These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 10626791)
1. Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene. Minaguchi T; Mori T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y Cancer Res; 1999 Dec; 59(24):6063-7. PubMed ID: 10626791 [TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo. Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320 [TBL] [Abstract][Full Text] [Related]
3. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3. Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531 [TBL] [Abstract][Full Text] [Related]
4. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Lu Y; Lin YZ; LaPushin R; Cuevas B; Fang X; Yu SX; Davies MA; Khan H; Furui T; Mao M; Zinner R; Hung MC; Steck P; Siminovitch K; Mills GB Oncogene; 1999 Nov; 18(50):7034-45. PubMed ID: 10597304 [TBL] [Abstract][Full Text] [Related]
5. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719 [TBL] [Abstract][Full Text] [Related]
6. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703 [TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cheney IW; Johnson DE; Vaillancourt MT; Avanzini J; Morimoto A; Demers GW; Wills KN; Shabram PW; Bolen JB; Tavtigian SV; Bookstein R Cancer Res; 1998 Jun; 58(11):2331-4. PubMed ID: 9622068 [TBL] [Abstract][Full Text] [Related]
8. Suppression of gastric cancer growth by adenovirus-mediated transfer of the PTEN gene. Hang Y; Zheng YC; Cao Y; Li QS; Sui YJ World J Gastroenterol; 2005 Apr; 11(15):2224-9. PubMed ID: 15818730 [TBL] [Abstract][Full Text] [Related]
10. Enhanced cell growth inhibition following PTEN nonviral gene transfer using polyethylenimine and photochemical internalization in endometrial cancer cells. Maurice-Duelli A; Ndoye A; Bouali S; Leroux A; Merlin JL Technol Cancer Res Treat; 2004 Oct; 3(5):459-65. PubMed ID: 15453811 [TBL] [Abstract][Full Text] [Related]
11. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Furnari FB; Huang HJ; Cavenee WK Cancer Res; 1998 Nov; 58(22):5002-8. PubMed ID: 9823298 [TBL] [Abstract][Full Text] [Related]
12. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Unoki M; Nakamura Y Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141 [TBL] [Abstract][Full Text] [Related]
13. PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancer. Tanaka M; Rosser CJ; Grossman HB Cancer Detect Prev; 2005; 29(2):170-4. PubMed ID: 15829377 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes. Cheney IW; Neuteboom ST; Vaillancourt MT; Ramachandra M; Bookstein R Cancer Res; 1999 May; 59(10):2318-23. PubMed ID: 10344736 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of PTEN increases sensitivity to SN-38, an active metabolite of the topoisomerase I inhibitor irinotecan, in ovarian cancer cells. Saga Y; Mizukami H; Suzuki M; Kohno T; Urabe M; Ozawa K; Sato I Clin Cancer Res; 2002 May; 8(5):1248-52. PubMed ID: 12006545 [TBL] [Abstract][Full Text] [Related]
16. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505 [TBL] [Abstract][Full Text] [Related]
17. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation. Rosser CJ; Tanaka M; Pisters LL; Tanaka N; Levy LB; Hoover DC; Grossman HB; McDonnell TJ; Kuban DA; Meyn RE Cancer Gene Ther; 2004 Apr; 11(4):273-9. PubMed ID: 14765130 [TBL] [Abstract][Full Text] [Related]
18. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Yuan XJ; Whang YE Oncogene; 2002 Jan; 21(2):319-27. PubMed ID: 11803475 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer. Sakurada A; Hamada H; Fukushige S; Yokoyama T; Yoshinaga K; Furukawa T; Sato S; Yajima A; Sato M; Fujimura S; Horii A Int J Oncol; 1999 Dec; 15(6):1069-74. PubMed ID: 10568810 [TBL] [Abstract][Full Text] [Related]
20. PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells. Stewart AL; Mhashilkar AM; Yang XH; Ekmekcioglu S; Saito Y; Sieger K; Schrock R; Onishi E; Swanson X; Mumm JB; Zumstein L; Watson GJ; Snary D; Roth JA; Grimm EA; Ramesh R; Chada S Mol Med; 2002 Aug; 8(8):451-61. PubMed ID: 12435856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]